PRIMS® is a digital assessment tool that performs neurological assessments using depth cameras to aid in the management of your journey with Parkinson’s Disease.

PRIMS® (Parkinson's Remote Interactive Management System) is a cutting-edge digital solution designed to revolutionize the management of neurological conditions like Parkinson’s Disease. With real-time motor assessments using 3D cameras, remote monitoring, and comprehensive reporting, PRIMS® empowers people with Parkinson's with personalized care and supports healthcare providers with accurate data for better assessments and treatment planning.

PRIMS® improves the quality of care for people with Parkinson's by offering precise, data-driven insights that enable healthcare providers to make more informed decisions, resulting in more targeted treatments and better outcomes.

PRIMS® empowers people with Parkinson's by providing a comprehensive, real-time digital assessment tool that enhances their understanding and management of neurological conditions, leading to more personalized and effective care.

PRIMS® meets the gold standard of assessments by adhering to the MDS-UPDRS guidelines, ensuring precise, validated evaluations that align with the highest clinical standards in neurological care.

PRIMS® improves access to care for people in rural areas by offering remote, digital assessments that make it easier for local healthcare providers to deliver high-quality neurological evaluations.

Bronwyn Bridges and Gord Genge are the co-founders of PragmaClin®, combining their expertise in science and healthcare to drive innovation in the MedTech industry.

Bronwyn, PhD candidate, who was named one of Atlantic Canada’s 30 Under 30, is the CEO of PragmaClin® and has helped develop, PRIMS, a digital assessment tool for neurological conditions like Parkinson’s Disease. She has secured over two million dollars in funding through grants and pitch competitions, has published research in the Parkinson’s Disease space, and has earned numerous awards for her work in digital health.

Gord, with degrees in biology, education, and architecture, has collaborated with leading institutions on microbial and biomedical projects. He designed and operated a pilot fermentation processing plant and brings extensive scientific and entrepreneurial experience to PragmaClin®. Gord was diagnosed with Parkinson's Disease in 2019 and has since been on a mission to improve care for others like him.

Together, they are dedicated to advancing healthcare through digital solutions, improving medical outcomes with their innovative approaches.